Our team of expert scientists has a wide range of capabilities to provide support services spanning preclinical development from cell biology, through in vivo efficacy models to clinical sample analysis.
We understand that in early phase clinical trials, biomarker efficacy data generated with only a small proportion of the clinical budget may crucially contribute to the decision to progress.
Our dedicated cell biology team will be able to help you identify and validate your targets; accelerate your hit-to-lead and lead optimisation; and characterise the mechanisms of action of your compounds.
Our bioanalytical services are frequently accessed by our clients to support in vivo and clinical studies.
In vivo studies
At KWS BioTest, we offer an extensive range of validated in vivo models of human disease to support your preclinical drug efficacy testing.
Our unique combination of expertise in immunology and infection studies makes KWS BioTest an ideal partner to support your vaccine research in all stages of preclinical and clinical development.